REG - Johnson Matthey PLC - Johnson Matthey Q1 AGM trading update
RNS Number : 8232GJohnson Matthey PLC29 July 2021AGM trading update
Johnson Matthey will hold its Annual General Meeting today at 11.00am and has issued the following trading update ahead of the meeting.
Strong first quarter with good momentum continuing
The year has started well, with a continuation of the good demand seen in the second half of 2020/21. In the first quarter we delivered strong sales¹ growth of 63% year-on-year, primarily driven by increased demand in Clean Air and also Efficient Natural Resources which benefited from higher precious metal prices and stronger end markets. Sales have returned to pre-pandemic levels, and operating profit is ahead driven by more volatile and higher average precious metal prices.
Clean Air
In Clean Air, the strong demand seen in the second half of 2020/21 was maintained. Sales growth in the first quarter was very strong in comparison with a weak Q1 2020/21 which was materially impacted by the pandemic. Sequentially, first quarter sales were moderately below Q4 2020/21 primarily driven by the impact of temporary supply chain disruption mostly in the light duty segment.
Automotive and truck OEMs are experiencing temporary supply chain disruption from shortages of semi-conductor chips, which affected production volumes in the period. Underlying vehicle demand remains strong and, whilst we anticipate continued volatility in the supply chain, we are confident that Clean Air will deliver strong operating performance and cash generation for the full year.
Efficient Natural Resources
Efficient Natural Resources had a strong start to the year, with sales up significantly in the first quarter compared to last year. This was primarily driven by PGM Services which benefited from volatile and higher average precious metal prices. Catalyst Technologies continues to see good momentum, with first quarter sales only moderately below the fourth quarter of the prior year, which is a seasonally strong period for orders. In the quarter, we signed one new licence and have a strong pipeline of projects.
Health
In Health, we expect strong growth for the full year. Sales for the first quarter lapped a strong quarter last year, and were also impacted by the phasing of customer orders in the current year. We continue to benefit from multi-year supply agreements with both our generics and innovators customers. As previously announced, we are conducting a strategic review of our Health business.
Hydrogen, Battery Materials and Value Businesses²
The world's adoption of hydrogen as an energy vector is accelerating, translating to faster than expected commercial prospects for our hydrogen growth businesses. In hydrogen fuel cells we continue to build our customer pipeline and recently signed a new agreement for the supply of membrane electrode assemblies (MEAs), mainly for commercial vehicles, with Unilia/REFIRE. We are also progressing a number of other key customer agreements for the supply of catalyst coated membranes (CCMs) for commercial vehicle and truck applications. We have begun work on significantly expanding our manufacturing capability in the UK and China, with the first phase on stream in early 2023 and further capacity expected to come on stream from 2024.
In green hydrogen production, testing with customers is proceeding well and we continue to expect first commercial sales from this business in 2022. Given the strong progress we have made with customers and the rapidly developing market, the recent acquisition³ of assets from Oxis Energy will enable us to further expand our manufacturing capability in the UK and accelerate our growth ambitions. This will provide hundreds of megawatts of additional capacity from the beginning of 2022.
In Battery Materials, commercialisation of our portfolio of eLNO high nickel cathode materials continues at pace and construction of our commercial plant remains on track.
In Value Businesses, sales grew reflecting a recovery in demand following COVID-19.
Outlook for the year ending 31st March 2022
Given the strength we are currently seeing in our end markets, we now expect at least mid teens growth in underlying operating4 performance at constant metal prices5 and constant currency.
At current foreign exchange rates6, translational foreign exchange movements for the year ending 31st March 2022 are expected to adversely impact underlying operating profit by c.£20 million.
Since our preliminary full year results announcement for 2020/21 at the end of May, precious metal prices have on average declined. Should metal prices remain at current levels7 for the rest of this year, we expect a full year net benefit of c.£65 million to underlying operating profit compared with the prior year.
Change to reporting segments
As mentioned in our preliminary full year results announcement in May, we are making small changes to our reporting segments for the year ending 31st March 2022. Restated historic numbers are given in the attached appendix (page 3).
Ends
Enquiries:
Investor Relations
Martin Dunwoodie
Louise Curran
Jane Crosby
Director of Investor Relations
Senior Investor Relations Manager
Investor Relations Manager
020 7269 8241
020 7269 8235
020 7269 8242
Media
Barney Wyld
Simon Pilkington
Group Corporate Affairs Director
Tulchan Communications
020 7269 8407
020 7353 4200
Notes:
Unless otherwise stated, commentary in this statement is based on sales for the quarter ended 30th June 2021 and compares this quarter with the quarter ended 30th June 2020 at constant rates.
1.
Sales - revenue excluding sales of precious metals to customers and the precious metal content of products sold to customers.
2.
Other Markets - we are making small changes to our reporting segments for the year ending 31st March 2022 as detailed in the appendix. New Markets includes our battery materials, fuel cells and green hydrogen businesses. Value Businesses includes Battery Systems, Medical Device Components as well as Diagnostic Services and Advanced Glass Technologies (both formerly part of Efficient Natural Resources) that are non-core.
3.
On 28th July 2021, Johnson Matthey announced the acquisition of assets and intellectual property from Oxis Energy Limited.
4.
Our previous guidance was for low to mid teens growth in underlying operating for the year ending 31st March 2022.
5.
Based on actual precious metal prices in 2020/21.
6.
Based on foreign exchange rates as at 26th July 2021. Our previous guidance was for an adverse impact to underlying operating profit of c.£25 million for the year ending 31st March 2022.
7.
Based on current precious metal prices as at 26th July 2021. Our previous guidance was for a net metal price benefit of up to c.£120 million for the year ending 31st March 2022.
Note: eLNO is a trademark of Johnson Matthey Public Limited Company.
Registered in England - Number 33774
LEI code: 2138001AVBSD1HSC6Z10
Appendix
Updated summary of operating results for the year ending 31st March 2021
As previously announced, we are making small changes to our reporting segments to reflect how we are managing our businesses and increase visibility of our new growth businesses, notably our hydrogen technologies. We have provided updated numbers for the half year ending 30th September 2020 and full year ending 31st March 2021 below.
Previous reporting segments Updated reporting segments
HY
FY
HY
FY
2020/21
2020/21
2020/21
2020/21
Sales excluding precious metal
As reported
As reported
Sales excluding precious metal
Restated
Restated
Clean Air
1,003
2,412
Clean Air
1,003
2,412
Total Light Duty Vehicle Catalysts
680
1,640
Total Light Duty Vehicle Catalysts
680
1,640
Total Heavy Duty Catalysts
310
741
Total Heavy Duty Catalysts
310
741
Other - stationary
13
31
Other - stationary
13
31
Efficient Natural Resources
446
1,057
Efficient Natural Resources
423
1,001
Catalyst Technologies
208
469
Catalyst Technologies
208
469
PGM Services
190
479
PGM Services
190
479
Advanced Glass Technologies
27
66
Life Science Technologies
25
53
Diagnostic Services
21
43
Health
119
237
Health
119
237
New Markets
168
356
Other Markets
191
412
Alternative Powertrain
101
225
New Markets
25
55
Medical Device Components
29
61
Value Businesses
166
357
Life Science Technologies
25
53
Other
13
17
Eliminations
(57)
(140)
Eliminations
(57)
(140)
Total sales
1,679
3,922
Total sales
1,679
3,922
HY
FY
HY
FY
2020/21
2020/21
2020/21
2020/21
As reported
As reported
Restated
Restated
Operating profit
Operating profit
Clean Air
77
269
Clean Air
77
269
Efficient Natural Resources
81
268
Efficient Natural Resources
88
274
Health
15
31
Health
15
31
New Markets
5
9
Other Markets
(2)
3
Corporate
(27)
(73)
Corporate
(27)
(73)
Total operating profit
151
504
Total operating profit
151
504
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDAGMBRGDRSBDDGBI
Recent news on Johnson Matthey
See all newsREG - Johnson Matthey PLC - Director Declaration
AnnouncementREG - Johnson Matthey PLC - Director/PDMR Shareholding
AnnouncementREG - Johnson Matthey PLC - Director/PDMR Shareholding
AnnouncementREG - Johnson Matthey PLC - Director/PDMR Shareholding
AnnouncementREG - Johnson Matthey PLC - Update on Catalyst Technologies sale
Announcement